Prellis Biologics

Prellis Biologics is a biotechnology company focused on revolutionizing antibody discovery. Their unique approach combines human biology and machine learning to accelerate the development of life-changing antibody therapeutics. Their EXIS™ platform utilizes 3D bioprinted lymph node organoids (LNO™) to mimic the complex biology of the human immune system, enabling them to access a vast diversity of antibodies in vitro. This process allows them to identify promising antibody candidates with low immunogenic risk, potentially reducing the time and cost of drug development.

Prellis Biologics has garnered significant attention for their innovative technology and has secured partnerships with major pharmaceutical companies like Sanofi and Bristol Myers Squibb. The company is committed to collaborative efforts, believing that the combined expertise of research institutions and biopharma companies will lead to faster and more effective drug development. With their cutting-edge platform and dedicated team, Prellis Biologics is poised to make a significant impact on the future of antibody therapeutics.

Prellis Biologics is a fast-paced, innovative company that embraces flexibility and adapts quickly to new opportunities. As a startup, they can pivot when needed to stay at the forefront of the biotech landscape. While specific details about flexible work arrangements are not explicitly stated in the provided text, the emphasis on agility and adaptability suggests a willingness to consider individual needs and preferences when it comes to work schedules and location.

Prellis Biologics offers a comprehensive benefits package that includes medical, vision, and dental insurance, as well as a 401(k) retirement savings plan. The company infers these benefits from their job postings, but does not explicitly list them on their website.

Prellis Biologics is a biotechnology company dedicated to revolutionizing drug discovery by harnessing the power of the human immune system with tightly-integrated machine learning. They aim to develop next-generation antibody therapeutics with unparalleled speed, precision, and safety. Prellis's bioprinted lymph node organoid platform allows them to mine the vast diversity of the human antibody repertoire in vitro, enabling them to empower pharmaceutical partners with access to the most promising fully human antibody candidates, ultimately bringing life-changing treatments to patients faster than ever before.

Prellis Biologics cultivates a high-performing culture that emphasizes innovation, collaboration, agility, inclusivity, and a shared sense of purpose. They encourage their team to push the boundaries of antibody discovery with creativity and ingenuity, while fostering a welcoming and inclusive environment where diverse perspectives are valued. The company's nimble startup environment allows for quick adaptation to new opportunities and pivoting when needed, ensuring they remain at the forefront of the dynamic biotech landscape. Prellis Biologics prioritizes the impact their work has on patients' lives, creating a shared sense of purpose that drives the team forward while incorporating fun into their work through team-building activities and milestone celebrations.

Prellis Biologics strongly emphasizes a culture of inclusivity and diversity, recognizing that diverse perspectives and backgrounds lead to innovative solutions. They actively promote a welcoming and respectful environment for all team members, fostering collaboration and valuing contributions from individuals with a wide range of skills and experiences. The company embraces agility and flexibility, adapting to new opportunities and challenges with a focus on inclusivity and purpose-driven work.